Neurointervention.  2009 Aug;4(2):94-100.

Percutaneous Transluminal Angioplasty for Brain Ischemia due to Takayasu's Arteritis

Affiliations
  • 1Department of Radiology, Asan Medical Center, University of Ulsan, College of Medicine, Korea. dcsuh@amc.seoul.kr
  • 2Department of Radiology, Daejeon St. Mary's Hospital, Catholic University, College of Medicine, Korea.

Abstract

PURPOSE
To report the follow-up results of percutaneous transluminal angioplasty (PTA) of supra-aortic arteries in patients presenting with neurological manifestations caused by Takayasu's arteritis.
MATERIALS AND METHODS
PTA was performed in four consecutive patients (women, age range 33-38 years) with Takayasu's arteritis (TA) with neurological manifestations (i.e., stroke, visual disturbance, and dizziness) caused by stenoocclusive lesions of supra-aortic arteries.
RESULTS
PTA was attempted on 5 lesions: VA (n=3), subcalvain artery (n=1), and brachiocephalic artery (n=1). PTA was performed successfully in all patients. The neurological manifestations of the patients were improved after angioplasty. There was no immediate procedure-related complication or neurologic deficits and no restenosis on follow-up angiography in three patients. All patients were neurologically stable without occurrence of further neurological deficit during follow-up periods (9 months - 7 years).
CONCLUSION
PTA of supra-aortic arteries in TA is safe and effective and provides good symptomatic relief in some patients with symptomatic multifocal stenoocclusive lesions of arch arteries.

Keyword

Arteritis; Takayasu's arteritis; Percutaneous transluminal angioplasty; Balloon angioplasty; Cerebral ischemia; Neurological manifestations

MeSH Terms

Angiography
Angioplasty*
Angioplasty, Balloon
Arteries
Arteritis
Brain Ischemia*
Brain*
Follow-Up Studies
Humans
Neurologic Manifestations
Stroke
Takayasu Arteritis*
Full Text Links
  • NI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr